Send til en ven
google +
Printervenlig version

Nyheder (Udbredte og kroniske sygdomme)

This section on health in the EU has been created as a trustworthy gateway to a wide range of information and data on health-related issues and activities at both European, national and international level. The content is produced by the European Commission, the Member States of the EU and the European Economic Area (EEA), plus EU candidate countries; by international organisations; and by pan-European non-governmental organisations in the area of public health.

New stem cell therapy for ischaemic heart disease

An EU-funded project is looking into 'Cardiac stem cells' (CSCs) to tackle the problem of chronic heart failure in Europe. Whilst previous research has concentrated on cells from the patients themsel[...]

New resource for educators: Discussion games: Melanoma

Game to engage in a dialogue | Skin cancer exposed What is melanoma? How can it be prevented? How is it diagnosed and how is it treated? In this game, you get the chance to discuss the prevention an[...]

New resource for educators: Experimental protocol: Participate in research into atherosclerosis

Home › Experimental protocol: Participate in research into atherosclerosis Experimental protocol: Participate in research into atherosclerosis Experiment protocol | The biotechnology revolution Here[...]

New resource for educators: Experimental protocol: Join in the research to find a drug for Alzheimer's

Home › Experimental protocol: Join in the research to find a drug for Alzheimer's Experimental protocol: Join in the research to find a drug for Alzheimer's Alzheimer's is a neurodegenerative diseas[...]

New resource for educators: Discussion games: Obesity

Obesity is a complex disease involving multiple factors (genetic, environment, economic level, etc.). It also leads to many other diseases. In this game we propose a discussion of the ethical, legal[...]

New resource for educators: Experimental protocol: Investigating the genetic origins of obesity

Home › Experimental protocol: Investigating the genetic origins of obesity Experimental protocol: Investigating the genetic origins of obesity Family history plays a very important role in the predi[...]

NCD Programme at the 2014 World Cancer Congress

Global Education and Training Initiative Global Access to Pain Relief Initiative Global Initiative for Cancer Registry Development NCD Programme at the 2014 World Cancer Congress Discover how NCDs a[...]

Research Headlines - Why cancer drugs affect young children differently

Cancer drugs save lives, but they are highly toxic. Using the right amounts is crucial. EU-funded research focusing on doxorubicin, one of the main drugs used in chemotherapy, has generated new knowl[...]

News for the EORP Cardiomyopathy and Myocarditis Registry

On behalf of the Cardiomyopathy Executive Committee of the EURObservational Research Programme (EORP), we are pleased to announce the launch of the Long-Term Cardiomyopathies and Myocarditis Registry[...]

Association found between high cholesterol and breast cancer

An association between high blood cholesterol and breast cancer has been found in a study of more than 1 million patients over a 14 year time period in the UK. Read moreTopics: Basic Science, Cardiov[...]

Discarded surgery fat treats heart attacks

Stem cells from fat to be discarded during cardiac surgery can improve heart function, according to research from Frontiers in CardioVascular Biology (FCVB) 2014 in Barcelona, Spain. Read more. Topic[...]

First evidence for painless Atrial Fibrillation treatment

The first evidence for a shockless treatment for atrial fibrillation (AF) presented on Friday 4 July at Frontiers in CardioVascular Biology (FCVB) 2014 in Barcelona, Spain. Read more. Topics: Basic S[...]

Success Stories - Spotting inherited heart disease before it strikes

Idiopathic dilated cardiomyopathy (DCM) is a type of heart disease in which the organ's muscle becomes weaker. It can lead to heart failure and ventricular arrhythmia (a type of irregular heart beat)[...]

4 July - ESC Webinar: Problems and solutions in the management of resistant hypertension

On 4 July 2014 from 18:00 to 19:00 CET, join Morris Brown and Isabella Sudano for a live webinar on the 2013 ESC Guidelines on the management of Arterial Hypertension. for Free by 2 July Topics: Hype[...]

Czech Republic should improve primary care and prevention to reduce chronic disease, says OECD

Strengthening primary health care and prevention programmes would help stem the growing tide of diabetes and other chronic health conditions in the Czech Republic, according to a new OECD report.[...]

E-journal of Cardiology Practice: Renal nerve denervation unraveled. Is the dream over?

Renal nerve denervation is a technique that was first described in the last few years as a tool to control blood pressure in resistant hypertensive patients especially. Although several studies have [...]

1st European Roundtable Meeting Report out now!

Report of the European Roundtable Meeting Berlin, May 2014 The Roundtable took place in Berlin, Germany, on 16 May and focused on ‘Improving cancer care in Europe - Sharing best practice and learnin[...]

Research Headlines - A new look at treatments for childhood cancers

Children rarely develop tumours, but if they do, the prognosis is uncertain. Sometimes, the growth just disappears, without therapy. Unfortunately, few families are so lucky, and there are only a han[...]

GlobalRT launch new website

Global Education and Training Initiative Global Access to Pain Relief Initiative Global Initiative for Cancer Registry Development Please contact UICC for any questions GlobalRT launch an exciting n[...]

Research Headlines - Fighting Hepatitis B and liver cancer in West Africa

EU-funded researchers are identifying and treating patients with Hepatitis B virus (HBV) in West Africa with the aim of reducing their risk of dying from liver cancer. The researchers are also develo[...]

Call for expressions of interest as Commission appointees to the European Commission Expert Group on Cancer Control

European Commission - Representative of producers of products or service providers in the field of cancer Representatives of pati[...]

The European Commission establishes expert group on cancer control

On 3rd June 2014, the European Commission adopted a decision which establishes an expert group on cancer control. Cancer is still the second most common cause of death in the Union: in 2008, 2.5 mill[...]

Events - Webinar on IMI 2-Call 1 diabetes topic - 11 July 2014, Online

Translational approaches to disease modifying therapy of Type 1 Diabetes Mellitus (T1DM) is one of three IMI webinars on its 1st Call for proposals under IMI 2. For more information on the webinar an[...]

Watch the HFA webinar on Iron deficiency in heart failure - From evidence to practice

Get an update with key opinion leaders on the impact of iron deficiency (ID) on CHF patients' outcomes and quality of life (QoL) independent of anaemia, and a review of newly released guidelines for [...]

The EHRA White Book 2014 highlights growing use of complex therapies for heart rhythm abnormalities in Europe

The White Book reports on the current status of arrhythmia treatment in 49 of the 56 European Society of Cardiology (ESC) member countries for the year 2013. The new White Book is published in electr[...]

Scientific guideline: Draft reflection paper on the use of patient reported outcome (PRO) measures in oncology studies, draft: consultation open

The importance of the patient's point of view on their health status is fully acknowledged and such information may in principle be used in drawing regulatory conclusions regarding treatment effects.[...]

Plenary Session 5: Update and controversies in prostate cancer

“The 29th EAU Congress has been a success. Particularly the attendance of countries beyond Europe was very high, for example Latin American countries like Brazil and Venezuela,” said Prof. Per-Ander[...]

EAU14 Souvenir Session: Urological imaging is a highly evolving field but approaches should change

Imaging in urology is undergoing rapid changes but current research needs to change and should concentrate on well-designed and high quality studies, according to Prof. Peter Albers (DE).[...]

Patient Information launches first onco-urological topic: kidney cancer

EAU Patient Information has reached a veritable milestone with the launch of the first onco-urological information set. The series on kidney cancer offers medical information about diagnosis and trea[...]

ESUR 2014: An interview with Prof. Ellen Zwarthoff

Ahead of the 22nd ESUR meeting in Glasgow, Prof. Ellen Zwarthoff (Rotterdam, NL), biochemist and winner of this year's Dominique Chopin Award for significant achievements in urological research, talk[...]

Making diet count in cancer prevention

Cancer risk factors can be reduced by correct nutrition and physical activity, which are key elements in all recommendations for cancer prevention, such as the European code against cancer.[...]

Success Stories - DECIDE: enabling earlier diagnosis of dementia

DECIDE stands for 'Diagnostic Enhancement of Confidence by an International Distributed Environment'. This FP7 project brought together 13 partners from five European countries, with the Italian GARR[...]

Research Headlines - Better, faster treatment for children with cancer

ENCCA project helps to get better treatment more quickly to children and other young people suffering from the disease. EU-funded researchers are improving collaboration among cancer specialists work[...]

Commission decision establishing a Commission expert group on Cancer Control

Directorate General for Health & Consumers[...]

Novel coronary stent materials reduce heart inflammation risk

Tiny metal tubes called stents - which keep blood flowing through diseased coronary arteries by slowly releasing medication - have helped to save the lives of millions at risk of heart disease. Once [...]

EFA Patients will discuss at the European Parliament

Benefits of EU research on allergy, asthma and COPD On June 17th 2014, EFA invites all stakeholders interested in ongoing EU-funded research initiatives for allergy, asthma and COPD to the European P[...]

WHO launches new High Level Commission on Ending Childhood Obesity

At the 67th World Health Assembly, a new High-Level Commission on Ending Childhood Obesity was officially launched. This new Commission aims to gather the best possible advice on dealing with the cri[...]

Research Headlines - Targeting cancerous tumours with precision

EU-funded researchers have developed novel technology for treating cancer patients that could deliver drugs exactly where they are needed in the human body. The potential breakthrough, which combines[...]

European Week Against Cancer

This week is European Week Against Cancer (25-31 May). As the week falls on a political hiatus during an election year, The Association of European Cancer Leagues (ECL) are calling on NGOs and citiz[...]

More efforts needed to tackle rising obesity, says OECD

Most people in OECD countries are overweight or obese. The social and economic consequences of this epidemic are dramatic, exposing an increasing number of people to chronic diseases such as diabetes[...]

Every day should be patients' rights day

Active Citizenship Network (ACN) decided to dedicate the 8th celebration of European Patients' Rights Day in 2014 to [...]

Success Stories - Regaining autonomy after a stroke - a major health challenge

Stroke is the most common neurological disease. It is also the most common cause of life-long impairment in adulthood and of institutionalisation, implying a change from a self-determined, independen[...]

Research Headlines - New tool in battle against Alzheimer's, Parkinson's

A more powerful mass spectrometer developed by EU-funded researchers could potentially lead to better treatments for patients with degenerative brain diseases such as Alzheimer's and Parkinson's. In [...]

IARC/WHO & IACR launch cancer registry guidelines

Lyon, France, 26 May 2014 - The International Agency for Research on Cancer (IARC) , the World Health Organization (WHO) , and the International Association of Cancer Registries (IACR) today launch [...]

Combined use of medicines affecting the renin-angiotensin system (RAS) to be restricted – CHMP endorses PRAC recommendation

The European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has endorsed restrictions on combining different classes of medicines that act on the renin-angiotensin system (R[...]

E-journal of Cardiology Practice on Secondary prevention of non-cardioembolic stroke

Highlighted for you in this article are the risk factor management and pharmaceutical strategy recommendations for secondary prevention of non-cardioembolic stroke according to the evidence reviewed [...]

E- journal of Cardiology Practice Likely features of female coronary artery disease

A woman complaining of chest pains might have a compromised anamnestic record, systolic arterial hypertension, abdominal obesity, diabetes, lipid metabolism disturbances, a habit of smoking, psychoso[...]

Childhood obesity and tuberculosis on agenda on first day of World Health Assembly

The Sixty-seventh World Health Assembly, WHO's annual global meeting of ministers and senior health officials, opened on 19 May 2014.[...]

Events - 8th Alpine Meeting: Current & Future challenges of oncology drug development - 29-31 October 2014, Buchen/Innsbruck, Austria

Scientific meeting between experts from academia, regulatory authorities and pharmaceutical industry to discuss the latest challenges in oncology drug development. Topics to be covered: Biomarkers fo[...]

Invitation to attend Heart Failure 2015 in Seville, Spain

We have the honour of inviting you to attend the Heart Failure 2015 meeting that will be held in Seville, Spain, from 23 to 26 May 2015. Topics: Heart Failure (HF)[...]

Study group on Peripartum Cardiomyopathy

The Study Group on Peripartum Cardiomyopathy was formed by the ESC in 2010 with the objective of bringing together specialists from a variety of disciplines to facilitate better understanding and man[...]

Novel device successfully treats central sleep apnoea in heart failure

A novel device implanted under the skin like a pacemaker successfully treats central sleep apnoea (CSA) in heart failure patients. The one year results of the remede® system pilot study were revealed[...]

TOPCAT reveals regional differences in spironolactone effectiveness for HFpEF

Adding spironolactone to existing treatments does not significantly reduce the composite primary outcome in patients with HF and preserved ejection fraction (HFpEF), reported the phase 3 TOPCAT study[...]

Heart failure hospitalisation more than doubles in IBD flares

Dr Søren L. Kristensen, lead author, said: [...]

Cardiovascular diseases rise during Greek financial crisis

Hospital admissions for cardiovascular diseases increased during the Greek financial crisis, according to two studies from Athens. Dr Alexios Samentzas said: [...]

Biomarker test for Peripartum Cardiomyopathy could help reduce death after giving birth

Cardiologists have discovered biomarkers that can be used to develop a screening test to detect Peripartum Cardiomyopathy (PPCM), a life-threatening disorder that is the primary cause of mortality in[...]

Negative iron balance predicts acute heart failure survival

Professor Ewa Jankowska, first author of the study, said: [...]

How could emergency care be improved for patients with acute heart failure?

Welcome to the European Society of Cardiology . Our mission: to reduce the burden of cardiovascular disease in Europe Professor Sean Collins Represents the Society for Academic Emergency Medicine Va[...]

Highllights on the World Congress on Acute Heart Failure

Find out how the World Congress of Acute Heart Failure offers a great opportunity for several specialties, including cardiologists and emergency physicians, to come together to share their views on A[...]

Sleeping pills increase CV events in heart failure patients

Sleeping pills increase the risk of cardiovascular events in heart failure patients by 8-fold, according to research from Japan. Dr Masahiko Setoguchi said: [...]

A new Cancer Staging Tool is now available for free access

Global Initiative for Cancer Registry Development A new Cancer Staging Tool is now available for free access A collaboration of the Northern Ireland Cancer Registry (NICR) and the International Agen[...]

Cancon Newsletter (Cancer Control Joint Action)    Canconpdf

Newsletter produced by Cancon - ancer Control Joint Action. Cancon is a European Commission co-funded Joint Action on comprehensive cancer control


CARDIOSTIM-EHRA EUROPACE 2014 presents the latest research on heart rhythm treatment and devices

The congress will take place from 18-21 June 2014 at the Acropolis Convention Centre in Nice, France. This year marks the first time Cardiostim and EHRA have collaborated to bring the scientific aspe[...]

Prevent premature deaths from heart failure, urges the Heart Failure Association

Awareness of Heart Failure is alarmingly poor among the general public and healthcare professionals alike. Policy initiatives that prioritise heart failure prevention and champion equity of care for [...]

Success Stories - Scientists report an important breakthrough in colon cancer treatment

EU researchers have used molecular tests to point the way to more effective therapy for patients with a previously untreatable form of colon cancer.[...]

Sports field transformed for breast cancer

Melbourne, 10th May 2014 - 15,000 people stood together in the name of breast cancer awareness on Australia's principal sporting ground, the MCG, in the shape of BCNA's iconic Pink Lady logo. read mo[...]

Sporting field transformed for breast cancer

Melbourne, 10th May 2014 - 15,000 people stood together in the name of breast cancer awareness on Australia's principal sporting ground, the MCG, in the shape of BCNA's iconic Pink Lady logo. read mo[...]

The shape of things to come: study predicts increase in adult obesity prevalence in almost all European countries by 2030

Rates of obesity and overweight in both male and females are projected to increase in almost all countries of Europe by 2030, according to a statistical modelling study. However, the forecast rates v[...]

Review of Corlentor/Procoralan started

The European Medicines Agency has started a review of the medicine Corlentor/Procoralan (ivabradine). Corlentor/Procoralan is used to treat the symptoms of adults with long-term stable angina (chest [...]

IARC Publications - PDFs online - Manual for Cancer Registry Personnel

IARC Technical Report No. 10 Edited by D. Esteban, S. Whelan, A. Laudico, D.M. Parkin[...]

Press Release: World Asthma Day 2014

Improving air quality can limit the symptoms of asthma and other breathing problems in children and adults, say HEAL/EFA on the launch of the “ Know your air for health ” website today. Information [...]

[ToyBox project report] Obesity prevention in children in pre-school years: policies and evidence

On 30 April 2014, the World Obesity Federation (formerly the International Association for the Study of Obesity) published its report [...]

World Asthma Day

World Asthma Day 2014 Asthma is a disease characterized by recurrent attacks of breathlessness and wheezing, which vary in severity and frequency. An asthma attack is the result of an inflammation of[...]

EU Public Health and Chronic Diseases

First ever EU Summit on Chronic Diseases On April 3 and 4, the European Commission organised the first ever EU Summit on Chronic Diseases. The World Health Organisation estimates that chronic disease[...]

Eplerenone reduces primary endpoint in acute myocardial infarction patients

A drug known to reduce mortality rate in patients with heart failure has now been found significantly effective when administered early in patients following an acute (ST elevated) myocardial infarct[...]

2014 World Cancer Congress

Register now and benefit from early bird savings! The 2014 World Cancer Congress will take place in Melbourne, Australia on 3-6 December 2014. read more[...]

Speech by President Barroso: Slovakia at the Heart of Europe

European Commission [Check Against Delivery] José Manuel Durão Barroso President of the European Commission University of Bratislava Bratislava, 28 April 2014 Thank you Mr. Rector, Thank you Prime Mi[...]

Scientific guideline: Guideline on the role of the pathological Complete Response as an endpoint in neoadjuvant breast cancer studies, draft: consultation open

Guideline on the role of the pathological Complete Response as an endpoint in neoadjuvant breast cancer studies Guideline on the role of the pathological Complete Response as an endpoint in neoadjuv[...]

European cancer information – new series of factsheets

A new series of factsheets published by the JRC and the European Network of Cancer Registries (ENCR) provide a unique overview of the cancer disease burden in Europe. They collect, condense and commu[...]

European Medicines Agency recommends approval of Mekinist for the treatment of melanoma

The European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has recommended marketing authorisation for Mekinist (trametinib) for the treatment of adult patients with unrese[...]

European Medicines Agency recommends extending use of Nexavar to include treatment of differentiated thyroid cancer

The European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has recommended extending the use of the cancer medicine Nexavar (sorafenib) to the treatment of progressive, loc[...]

No ban for TV ad showing link between alcohol and cancer

Attempts by the alcohol industry to ban a TV advertisement linking their products with an increased risk of developing cancer have failed.[...]

The world’s largest heart failure congress

Media alert: The latest scientific advances and emerging therapies in heart failure will be showcased at Heart Failure 2014, The core of which is the presentation of original scientific research: bre[...]

[EPHA report] EU Summit on Chronic Diseases

On 3 and 4 April 2014 in Brussels, the European Commission (EC) held the first ever [...]

A global view on the prevention of cardiovascular disease

The theme of this year's congress is [...]

The European Policy Action Network on Diabetes (ExPAND)

Almost one century after the discovery of insulin therapy , people who suffer from diabetes still continue facing physical and psychological pain. Last January, the European Policy Action Network on [...]

Access all the presentations from EuroHeartCare 2014

The ESC Council on Cardiovascular Nursing and Allied Professions has made the slides from all EuroHeartcongress presentations available here. Topics: Cardiovascular Nursing[...]

Professional groups: a key role in boosting prostate cancer research

Professional medical groups, particularly those operating in international and regional levels, play a vital role in boosting cancer research with future trends expected to emphasise intra-regional c[...]

PRAC recommends against combined use of medicines affecting the renin-angiotensin (RAS) system

The European Medicines Agency's Pharmacovigilance Risk Assessment Committee (PRAC) has reviewed the risks of combining different classes of medicines that act on the renin-angiotensin (RAS) system, a[...]

Periodontal disease associated with cardiovascular risk in large multicentre study

Should dental health now be considered a marker of coronary heart disease? Tooth loss and gingivitis have been identified as a potential risk marker for cardiovascular disease in a large study publis[...]


The European Commission is solely responsible for information present on EU-level websites, information present in the Portal originated by the Commission. National-level information is provided by the Member States concerned and Member States are solely responsible for the accuracy of the information. Likewise, the European Commission is not responsible for information on non-governmental organisations and international organisations websites. The European Union is committed to user privacy. Read more concerning the Legal Notice.
Further questions can be answered through the Contact page. The Health-EU portal supports principles and measures to increase the credibility of information on the net. It complies with the HONcode standard for trustworthy health information: verify here.